Genetic Disorders tests in Dubai & UAE

Compare available Genetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

136

Listed price range

1,100.00–4,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Disorders test prices

Showing 61–75 of 136 matching tests.

Genetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2390 FOXG1 Gene Sequencing Test This test evaluates the entire coding region of the FOXG1 gene for sequence changes, deletions, and duplications.	Peripheral Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FOXG1 gene sequence variants", "Copy Number Variants (CNVs) in FOXG1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Suspected congenital Rett syndrome", "Diagnosis of associated dysmorphology", "Family history suggestive of FOXG1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 98723-6 ICD-10: F84.2 Clinical summary This test evaluates the entire coding region of the FOXG1 gene for sequence changes, deletions, and duplications.
TEST-4499 FUCA1 Gene Fucosidosis Next‑Generation Sequencing (NGS) Genetic Test This genetic test sequences the FUCA1 gene to detect mutations associated with fucosidosis.	Peripheral whole blood (EDTA), dried blood spot, or extracted genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FUCA1 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of fucosidosis", "Family history of fucosidosis", "Need for carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94721-2 ICD-10: E77.1 Clinical summary This genetic test sequences the FUCA1 gene to detect mutations associated with fucosidosis.
TEST-2669 GDF3 Gene Klippel-Feil Syndrome Type 3, Autosomal Dominant Genetic Test This diagnostic test evaluates the GDF3 gene for pathogenic variants associated with Klippel-Feil syndrome type 3.	Peripheral blood, dried blood spot (FTA card), or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GDF3 gene", "Congenital cervical and thoracic vertebral fusion"] Parameters [] Preparation [] Indications ["Clinical suspicion of Klippel-Feil syndrome type 3", "Confirmed family history of Klippel-Feil syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81245-6 ICD-10: Q76.1 Clinical summary This diagnostic test evaluates the GDF3 gene for pathogenic variants associated with Klippel-Feil syndrome type 3.
TEST-6316 GLB1 Gene GM1 Gangliosidosis Type 1 Genetic Test This test identifies pathogenic variants in the GLB1 gene associated with GM1 gangliosidosis type 1.	Whole Blood (Peripheral) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GLB1 gene", "Copy number variations (CNVs) in the GLB1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected GM1 gangliosidosis type 1", "Family history of GM1 gangliosidosis type 1", "Need for molecular confirmation for prognosis and therapy", "Informed reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21656-0 ICD-10: E75.19 Clinical summary This test identifies pathogenic variants in the GLB1 gene associated with GM1 gangliosidosis type 1.
TEST-3512 GNAS Gene Pseudohypoparathyroidism Type 1A Genetic Test This test identifies pathogenic variants in the GNAS gene associated with pseudohypoparathyroidism type 1A.	Peripheral whole blood (EDTA), extracted DNA, or buccal swab (Oragene DNA collection kit)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in GNAS gene", "Copy-number changes in GNAS gene"] Parameters [] Preparation ["Genetic counselling is mandatory before sample collection"] Indications ["Clinical features of Albright's hereditary osteodystrophy", "Hormone resistance", "Unexplained hypocalcemia"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: E20.1 Clinical summary This test identifies pathogenic variants in the GNAS gene associated with pseudohypoparathyroidism type 1A.
TEST-6009 GPHN Gene Molybdenum Cofactor Deficiency Type C Genetic Test This genetic test identifies pathogenic variants in the GPHN gene associated with Molybdenum Cofactor Deficiency Type C.	Peripheral whole blood (EDTA) or buccal swab	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GPHN gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["Prior genetic counselling session (pedigree chart mandatory)"] Indications ["Clinical suspicion of Molybdenum Cofactor Deficiency Type C", "Family screening", "Prenatal/preimplantation options"] Measurement technique Confirm with laboratory Codes LOINC: 93722-8 ICD-10: E83.89, E83.09 Clinical summary This genetic test identifies pathogenic variants in the GPHN gene associated with Molybdenum Cofactor Deficiency Type C.
TEST-6390 GSS Gene Glutathione Synthetase Deficiency Genetic Test This genetic test evaluates the GSS gene for mutations associated with glutathione synthetase deficiency.	Whole Blood (EDTA, 3–5 mL), Extracted DNA, or FTA Card	3–4 Weeks (21–28 Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GSS gene mutations", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Avoid sample collection if patient has acute febrile illness.", "Inform laboratory if patient has had a bone marrow transplant."] Indications ["Suspected glutathione synthetase deficiency", "Family history of the disorder", "Evaluation of chronic hemolytic anemia"] Measurement technique Confirm with laboratory Codes LOINC: 94030-2 ICD-10: E72.89 Clinical summary This genetic test evaluates the GSS gene for mutations associated with glutathione synthetase deficiency.
TEST-2268 HOXD13 Gene Syndactyly Type 5 Genetic Test This test identifies pathogenic variants in the HOXD13 gene to confirm a diagnosis of syndactyly type 5 (SD5), a hereditary hand malformation.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HOXD13 gene", "Coverage of HOXD13 coding regions"] Parameters [] Preparation ["Pre-test genetic counseling session recommended", "No special sample preparation needed"] Indications ["Clinical suspicion of syndactyly type 5 (SD5)", "Family history of limb malformations", "Genetic counseling for recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q70.0, Q70.3 Clinical summary This test identifies pathogenic variants in the HOXD13 gene to confirm a diagnosis of syndactyly type 5 (SD5), a hereditary hand malformation.
TEST-3684 HPS1 Gene Hermansky-Pudlak Syndrome Type 1 Genetic Test This test identifies pathogenic mutations in the HPS1 gene, confirming a diagnosis of Hermansky-Pudlak syndrome type 1.	Whole Blood (EDTA) or FTA Card Specimen	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the HPS1 gene"] Parameters [] Preparation ["Maintain all prescribed therapies unless directed by physician", "Abrupt discontinuation of antiplatelet agents or anticoagulants poses significant thrombotic risk"] Indications ["Diagnosis of Hermansky-Pudlak syndrome type 1", "Molecular confirmation for managing associated complications"] Measurement technique Confirm with laboratory Codes LOINC: 90291-7 ICD-10: E70.3 Clinical summary This test identifies pathogenic mutations in the HPS1 gene, confirming a diagnosis of Hermansky-Pudlak syndrome type 1.
TEST-5389 HR Gene Atrichia with Papular Lesions Genetic Test This genetic test analyzes the HR gene for mutations causing Atrichia with Papular Lesions (APL). It identifies biallelic loss-of-function mutations associated with the disorder.	Peripheral whole blood (EDTA), extracted DNA, or FTA card (finger‑prick)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HR gene coding regions", "HR gene splice junctions", "Pathogenic variants in HR gene"] Parameters [] Preparation [] Indications ["Suspected Atrichia with Papular Lesions (APL)", "Differential diagnosis of congenital hair loss disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q84.0, L63.8 Clinical summary This genetic test analyzes the HR gene for mutations causing Atrichia with Papular Lesions (APL). It identifies biallelic loss-of-function mutations associated with the disorder.
TEST-6224 INSR Gene Diabetes Mellitus, Insulin-Resistant with Acanthosis Nigricans Genetic Test This genetic test evaluates the insulin receptor gene (INSR) for variants associated with severe insulin resistance and diabetes mellitus.	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	21–28 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the INSR gene", "Copy Number Variations (CNV) in the INSR gene"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9% (full gene coverage + CNV)"}] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Diagnosis of monogenic severe insulin-resistant diabetes mellitus", "Evaluation of severe insulin resistance with acanthosis nigricans"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E11.8 Clinical summary This genetic test evaluates the insulin receptor gene (INSR) for variants associated with severe insulin resistance and diabetes mellitus.
TEST-3897 IQCE Gene Autism Genetic Test This test identifies pathogenic variants in the IQCE gene associated with Autism Spectrum Disorder.	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in IQCE gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Diagnosis of Autism Spectrum Disorder", "Familial recurrence risk assessment for ASD", "Personalized therapeutic planning for ASD"] Measurement technique Confirm with laboratory Codes LOINC: 81265-4 ICD-10: F84.0 Clinical summary This test identifies pathogenic variants in the IQCE gene associated with Autism Spectrum Disorder.
TEST-2407 IRF6 Gene (Popliteal Pterygium Syndrome Type 1) Genetic Test This genetic test analyzes the IRF6 gene to identify pathogenic variants associated with Popliteal Pterygium Syndrome Type 1 (PPS1). It helps confirm the diagnosis and guide clinic...	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IRF6 gene sequence", "Pathogenic variants in IRF6"] Parameters [] Preparation [] Indications ["Diagnosis of Popliteal Pterygium Syndrome Type 1 (PPS1)", "Differentiation from Van der Woude Syndrome", "Recurrence risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 92282-3 ICD-10: Q87.0, Q79.8 Clinical summary This genetic test analyzes the IRF6 gene to identify pathogenic variants associated with Popliteal Pterygium Syndrome Type 1 (PPS1). It helps confirm the diagnosis and guide clinical management.
TEST-2204 IRF6 Gene Van der Woude Syndrome Type 1 Genetic Test This genetic test identifies mutations in the IRF6 gene associated with Van der Woude syndrome Type 1.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs) in the IRF6 gene"] Parameters [] Preparation [] Indications ["Individuals presenting with cleft lip with or without cleft palate", "Congenital lip pits", "Family history suggestive of autosomal dominant inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 94139-6 ICD-10: Q87.0 Clinical summary This genetic test identifies mutations in the IRF6 gene associated with Van der Woude syndrome Type 1.
TEST-2804 IRX5 Gene Hamamy Syndrome Genetic Test This test identifies pathogenic variants in the IRX5 gene associated with Hamamy syndrome.	Whole Blood (EDTA tube, 3–5 mL), Extracted DNA (minimum 1 µg at 20 ng/µL), or Dried Blood Spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IRX5 gene", "Heterozygous, homozygous, and compound heterozygous variants"] Parameters [] Preparation ["No fasting required"] Indications ["Clinical suspicion of Hamamy syndrome", "Confirmation of diagnosis", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 10155-0 ICD-10: Q87.0, Z13.71, Z15.89 Clinical summary This test identifies pathogenic variants in the IRX5 gene associated with Hamamy syndrome.

Category overview

Genetic Disorders: overview

Understanding your family's risk for specific hereditary conditions empowers you to make proactive, highly informed health and reproductive decisions. As a core pillar of our advanced Genetics department, comprehensive testing for Genetic Disorders evaluates your DNA for a curated selection of mutations known to cause distinct, multi-system hereditary conditions. Utilizing state-of-the-art sequencing technology, this empowering molecular screening provides the critical clarity needed to assess carrier status and diagnostic risks, safely guiding informed family planning, proactive medical interventions, and specialized reproductive counseling. Widely respected for compassionate diagnostic excellence among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, uncompromising analytical accuracy, and rapid, dependable reporting. Safeguard your family’s future—book your genetic disorders testing in UAE, arrange a comfortable clinic or home sample collection, or connect with our specialized medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.